Health
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial – GlobeNewswire
NEW YORK and MAINZ, GERMANY, Sept. 12, 2020 (GLOBE NEWSWIRE) — NEW YORK and MAINZ, GERMANY, September 12 — Pfizer Inc. (NYSE: PFE) and BioNTech…
NEW YORK and MAINZ, GERMANY, Sept. 12, 2020 (GLOBE NEWSWIRE) —
NEW YORKand MAINZ, GERMANY, September 12 Pfizer Inc.
(NYSE: PFE) and BioNTech SE
(NASDAQ: BNTX) announced today that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to approximately 44,000 participants which also allows for the enrollment of new populations.
Enrollment in the trial has been proceeding as planned an…
-
Business22 hours agoBetashares reveals its 3 fastest-rising ASX ETFs of 2025 so far
-
Noosa News24 hours agoAndgar piggeries footage shows sow stalls in use, possible cannibalism
-
Noosa News19 hours agoBega sells peanut processing plants at Kingaroy and Tolga to family business
-
Noosa News19 hours agoBrisbane news LIVE updates: Queensland Police Commissioner Steve Gollschewski back on job after cancer treatment | Thief steals and crashes hearse